Standout Papers
- Prostate cancer (2015)
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven (2008)
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group (2022)
- Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol (2022)
Immediate Impact
3 by Nobel laureates 10 from Science/Nature 111 standout
Citing Papers
Prostate Cancer
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Gerhardt Attard being referenced
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
2022 Standout
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gerhardt Attard | 7948 | 4305 | 1995 | 3561 | 248 | 11.2k | |
| Mary‐Ellen Taplin | 8079 | 2564 | 2052 | 2601 | 199 | 9.6k | |
| David Olmos | 6034 | 3095 | 1382 | 3168 | 231 | 10.0k | |
| Andrew J. Armstrong | 10654 | 4376 | 3390 | 3746 | 415 | 14.0k | |
| Charles J. Ryan | 5872 | 2144 | 1996 | 2077 | 338 | 8.3k | |
| Paul N. Mainwaring | 6748 | 2360 | 2353 | 2325 | 142 | 9.0k | |
| Glenn J. Bubley | 7632 | 2719 | 1435 | 3607 | 163 | 11.9k | |
| William Kevin Kelly | 6118 | 2011 | 1854 | 4953 | 240 | 11.7k | |
| Thian Kheoh | 6057 | 2292 | 2248 | 1295 | 123 | 7.4k | |
| Eleni Efstathiou | 4556 | 1667 | 1236 | 1988 | 201 | 7.2k | |
| Jun Luo | 5565 | 3177 | 684 | 4514 | 144 | 9.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...